A Review on Hypertension

Q: What is the clinical evidence from this study?

Study design: Review. Population: Hypertension. Intervention: Technological advancements in blood pressure monitoring (smartphone apps, self-monitoring, tele-monitoring).

Q: What does this research mean for the field?

Emerging technologies such as tele-monitoring enhance the screening, diagnosis, and management of hypertension across the general population and special demographic groups. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

Chandan Das; P. K. Tudu

doi:10.61841/p02e2982

November 5, 2019International Journal of Psychosocial RehabilitationOpen Access

A Review on Hypertension

View Full Paper

Ask AI

Bookmark

Share

Key result

Digital tools show promise for hypertension management, but lack of validation limits clinical adoption.

Why the study?

Hypertension remains a leading global cause of morbidity and mortality with many cases undiagnosed or untreated, highlighting the need for improved detection and management strategies.

Key Points

To examine how emerging technologies and tele-monitoring can improve blood pressure screening, diagnosis, and management across general and high-risk populations.
Narrative review synthesizing clinical guidelines, epidemiological estimates from the World Health Organization, and literature on blood pressure screening modalities.
Evaluation of self-screening kiosks, cuffless monitors, wearable sensors, and mobile health applications across general populations and special groups, including older adults, pregnant women, and patients with atrial fibrillation.
Hypertension directly causes approximately 10,000,000 deaths per year worldwide, with around 33% of affected individuals remaining undiagnosed and approximately 50% of diagnosed patients not taking antihypertensive medications.
In England, over 2.1 million individuals under 45 years of age had hypertension in 2015, defined by NICE guidelines as clinic blood pressure of 140/90 mmHg or higher confirmed by daytime ambulatory averages of 135/85 mmHg or higher.
Although more than 185 commercial applications exist to measure pulse or blood pressure, only 3.9% involved medical experts during development, and none have received regulatory clearance from the US FDA or European Commission.

Structured PICO

P

Population

Individuals with or at risk of hypertension, including the general population, elderly, pregnant women, and those with atrial fibrillation.

I

Intervention

Technological advancements for blood pressure screening, diagnosis, and management (including self-monitoring devices, smartphone applications, and tele-monitoring).

While new technologies like mHealth and tele-monitoring show promise for improving hypertension screening and control, urgent regulatory frameworks and clinical validation standards are needed before widespread clinical adoption.

Limitations

Absence of an agreed standard for the clinical validation of smartphone apps and novel non-invasive devices.
Current market penetration of smartphones into older populations is inadequate.
Cognitive deficits, visual, or hearing weaknesses in older populations can reduce the accessibility of mobile health applications.
Accuracy of automated blood pressure devices is limited in patients with atrial fibrillation.
Absence of universally agreed standards for the validation of novel non-invasive devices and applications
Current protocols do not include these novel technologies
Inadequate market penetration of smartphones among the elderly
Cognitive, visual, or hearing impairments in older populations reduce the accessibility of smartphone applications

Implication

Clinicians should await validated tools before adopting smartphone hypertension monitoring; leaves open the need for standardized regulatory trials.

Abstract

Hypertension has been distinguished by WHO as one of the most critical hazardous factors for morbidness and mortality worldwide and is answerable for the passing of roughly 10,000,000 individuals every year. Hypertension is a key hazard factor for cardiovascular illness. Right now, around 33% of individuals with hypertension are undiscovered, and of those analyzed, around half are not taking antihypertensive prescriptions. The World Health Organization (WHO) measures that hypertension straightforwardly causes passing of individuals at a rate of 10,000,000 individuals each year. There is a developing pattern to enable patients to help hypertension screening and diagnosis, and a few examinations have indicated the advantage of tele-checking, especially when combined with co-intercession, in improving the administration of hypertension. In this audit, we look at how rising innovations may bolster improved discovery and the board of hypertension in the more extensive populace as well as inside exceptional populace gatherings, for example, the old, pregnant ladies, and those with atrial fibrillation.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Das et al. (2019) conducted a review in Hypertension. Technological advancements in blood pressure monitoring (smartphone apps, self-monitoring, tele-monitoring) was evaluated.

synapsesocial.com/papers/6ac591f938c9af7ead383486 https://doi.org/10.61841/p02e2982

View Full Paper

Ask AI

Bookmark

Share

A Review on Hypertension

Key Points

Structured PICO

Limitations

Implication

Abstract

Discussion

Cite This Study

A Review on Hypertension

Key Points

Structured PICO

Limitations

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading